Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Maintenance of healthy human metabolism depends on a symbiotic consortium among bacteria, archaea, viruses, fungi, and host eukaryotic cells throughout the human gastrointestinal tract. Microbial communities provide the enzymatic machinery and the metabolic pathways that contribute to food digestion, xenobiotic metabolism, and production of a variety of bioactive molecules. These include vitamins, amino acids, short-chain fatty acids (SCFAs), and metabolites, which are essential for the interconnected pathways of glycolysis, the tricarboxylic acid/Krebs cycle, oxidative phosphorylation (OXPHOS), and amino acid and fatty acid metabolism. Recent studies have been elucidating how nutrients that fuel the metabolic processes impact on the ways immune cells, in particular, macrophages, respond to different stimuli under physiological and pathological conditions and become activated and acquire a specialized function. The two major inflammatory phenotypes of macrophages are controlled through differential consumption of glucose, glutamine, and oxygen. M1 phenotype is triggered by polarization signal from bacterial lipopolysaccharide (LPS) and Th1 proinflammatory cytokines such as interferon-γ, TNF-α, and IL-1 β, or both, whereas M2 phenotype is triggered by Th2 cytokines such as interleukin-4 and interleukin-13 as well as anti-inflammatory cytokines, IL-10 and TGF β, or glucocorticoids. Glucose utilization and production of chemical mediators including ATP, reactive oxygen species (ROS), nitric oxide (NO), and NADPH support effector activities of M1 macrophages. Dysbiosis is an imbalance of commensal and pathogenic bacteria and the production of microbial antigens and metabolites. It is now known that the gut microbiota-derived products induce low-grade inflammatory activation of tissue-resident macrophages and contribute to metabolic and degenerative diseases, including diabetes, obesity, metabolic syndrome, and cancer. Here, we update the potential interplay of host gut microbiome dysbiosis and metabolic diseases. We also summarize on advances on fecal therapy, probiotics, prebiotics, symbiotics, and nutrients and small molecule inhibitors of metabolic pathway enzymes as prophylactic and therapeutic agents for metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to regulation of infection and commensal spread, microbiome-immune interactions are implicated in a variety of ‘non-communicable’ gastrointestinal diseases including inflammatory bowel disease (IBD)8 and celiac diseases,9 as well as extra-intestinal disorders ranging from rheumatic arthritis,10 metabolic syndrome,11 neurodegenerative disorder12 to malignancy.13”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [11]
In the citing paper
“Changes in this microbial equilibrium that is, dysbiosis can promote and influence the course of many intestinal and extra-intestinal diseases[14-16].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 2×
“Unstimulated macrophages displaying M0 phenotype and exhibiting the differentiation surface markers CD68/ CD80//CD206 acquire and display the M1 phenotype (CD68/CD80//CD206) or M2 phenotype (CD68/ CD80/CD206/) after switching their metabolism and function in response to stimuli or polarization signals that initiate a…”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Initial clues for the role of microorganisms in energy homeostasis and obesity appeared from the studies using germ-free animals [76].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425 · cited 1×
“A collection of 100-400× 10(12) of bacteria inhabits and lives in mutualistic relationships in the human GI tract [3].”
BackgroundMiller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,105 · cited 1×
“Finally, bacteria can inhibit the growth of their competitors by long distance microbial communication, via release of metabolites and quorum sensing peptides, which are considered a biological strategy for maintenance of density of commensal species, and elimination of pathogenic bacteria [23, 24].”
Background
Cited by
Items 101–200 of 397
Marascio, N., Scarlata, G. G. M., Romeo, F., Cicino, C., Trecarichi, E. M., Quirino, A., Torti, C., Matera, G., & Russo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119307 · Cited by 32
Jarmakiewicz-Czaja, S., Sokal-Dembowska, A., & Filip, R. (2020) · Nutrients · doi:10.3390/nu12103073 · Cited by 32
“In addition, bacterial lipopolysaccharide (LPS) may trigger a signal to induce low-grade inflammation that contributes to diabetes, obesity and the metabolic syndrome [83].”
BackgroundMetabolic plasticity enables lifestyle transitions of Porphyromonas gingivalis
Moradali, M. F., & Davey, M. E. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00217-4 · Cited by 30
Vezza, T., Garrido‐Mesa, J., Diez‐Echave, P., Hidalgo‐Garcia, L., Ruiz‐Malagón, A. J., García, F., Sánchez, M., Toral, M., Romero, M., Duarte, J., et al. (2021) · Nutrients · doi:10.3390/nu13082595 · Cited by 30
“Thus, it can prompt the development of metabolic diseases [63].”
BackgroundThe microbiota–gut–brain axis: A novel nutritional therapeutic target for growth retardation
Qi, M., Tan, B., Wang, J., Liao, S., Deng, Y., Ji, P., Song, T., Zha, A., & Yin, Y. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1879004 · Cited by 29
Diet, Probiotics and Physical Activity: The Right Allies for a Healthy Microbiota
Divella, R., Palma, G. D., Tufaro, A., Pelagio, G., Gadaleta‐Caldarola, G., Bringiotti, R., & Paradiso, A. (2021) · Anticancer Research · doi:10.21873/anticanres.15057 · Cited by 29
Antioxidant and Antibacterial Effects of Potential Probiotics Isolated from Korean Fermented Foods
Sathiyaseelan, A., Saravanakumar, K., Han, K., Naveen, K. V., & Wang, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710062 · Cited by 29
Lei, Y., Xu, M., Huang, N., & Yuan, Z. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1154888 · Cited by 29
“The increase in GSH and NO may be associated with a reduction in the metabolic syndrome of the patient (39).”
BackgroundFunctional Fermented Milk with Fruit Pulp Modulates the In Vitro Intestinal Microbiota
Borgonovi, T. F., Salgaço, M. K., de Oliveira, G. L. V., de Carvalho, L. A. L., Pinheiro, D. G., Todorov, S. D., Sivieri, K., Casarotti, S. N., & Penna, A. L. B. (2022) · Foods · doi:10.3390/foods11244113 · Cited by 28
de Lima, A. P., Rogero, M. M., Viel, T. A., Garay-Malpartida, M., Aprahamian, I., & Ribeiro, S. M. L. (2021) · The journal of nutrition health & aging · doi:10.1007/s12603-021-1720-5 · Cited by 28
Self-citationFatty liver and alteration of the gut microbiome induced by diallyl disulfide
Yang, Y., Yang, F., Huang, M., Wu, H., Yang, C., Zhang, X., Yang, L., Chen, G., Li, S., Wang, Q., et al. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4350 · Cited by 27
“Gut microbiota provide the enzymatic and metabolic pathways involved in food digestion, xenobiotic metabolism and production of molecules such as amino acids, short-chain fatty acids and metabolites, which are essential for glycolysis, the tricarboxylic acid cycle, oxidative phosphorylation, and amino acid and fatty a…”
BackgroundSenesi, P., Ferrulli, A., Luzi, L., & Terruzzi, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157772 · Cited by 27
“An unbalanced ratio of Firmicutes/Bacteroidetes, the two principal phyla of gut microbiota, damages the gut mucosal barrier and thus increasing the translocation of lipopolysaccharide (LPS), which is a component of Gram-negative bacteria, as well as contributing to the activation of inflammatory pathways, including To…”
BackgroundEfficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy
Nagase, N., Ikeda, Y., Tsuji, A., Kitagishi, Y., & Matsuda, S. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.150 · Cited by 27
Leite, G., Barlow, G. M., Rashid, M. A., Hosseini, A., Cohrs, D., Parodi, G., Morales, W., Weitsman, S. R., Rezaie, A. R., Pimentel, M., et al. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002790 · Cited by 27
“Imbalances in gut microbial populations have repeatedly been reported in patients with obesity-related diseases (10 – 13).”
BackgroundHost Immunity Influences the Composition of Murine Gut Microbiota
averbeke, V. V., Berkell, M., Mysara, M., Ruiz, J. P. R., Xavier, B. B., Winter, F. D., Jongers, B. ‘., Jairam, R. K., Hotterbeekx, A., Goossens, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828016 · Cited by 26
Paepe, E. D., Plekhova, V., Vangeenderhuysen, P., Baeck, N., Bullens, D. M. A., Claeys, T., Graeve, M. D., Kamoen, K., Notebaert, A., de Wiele, T. V., et al. (2024) · Allergy · doi:10.1111/all.16005 · Cited by 26
“Alterations in AAs were also observed and could be linked to either dysbiosis 41 and/or inflammation.”
BackgroundRole of Micronutrients and Gut Microbiota-Derived Metabolites in COVID-19 Recovery
Hernández-Flores, T. D. J., Pedraza‐Brindis, E. J., Cárdenas-Bedoya, J., Ruíz-Carrillo, J. D., Méndez-Clemente, A. S., Martinez-Guzman, M. A., & Íñiguez-Gutiérrez, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012324 · Cited by 25
Zhao, Q., Yang, F., Pu, Q., Zhao, R., Jiang, S., & Tang, Y. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106229 · Cited by 25
Hiremath, S. S., & Viswanathan, P. (2022) · Anaerobe · doi:10.1016/j.anaerobe.2022.102572 · Cited by 25
Gut Barrier Dysfunction and Microbiota Variations in Cryptosporidiosis: A Comprehensive Review
Ali, M., Xu, C., Wang, M., Hina, Q., Ji, Y., Anwar, S., Lü, S., He, Q. H., Qiu, Y., & Li, K. (2025) · Veterinary Sciences · doi:10.3390/vetsci12020085 · Cited by 24
“In addition, reduced bacterial diversity in the host gut is associated with a weakened immune response and the dominance of potentially harmful bacteria [55,57].”
Obesity: More Than an Inflammatory, an Infectious Disease?
Leocádio, P. C. L., Oriá, R. B., Lopez, M. E. C., & Alvarez-Leite, J. I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03092 · Cited by 24
“Other minor phyla are Actinobacteria, Proteobacteria, Fusobacteria, and Verrucomicrobia (8).”
BackgroundYanuck, S. F., Pizzorno, J. E., Messier, H., & Fitzgerald, K. N. (2020) · PubMed Central · Cited by 24
The Urinary Microbiome; Axis Crosstalk and Short-Chain Fatty Acid
Yang, H. J., Kim, D. S., Lee, K. W., & Kim, Y. H. (2022) · Diagnostics · doi:10.3390/diagnostics12123119 · Cited by 24
Rodenes-Gavidia, A., Lamelas, A., Bloor, S., Hobson, A. R., Treadway, S., Haworth, J. J., Vijayakumar, V., Naghibi, M., Day, R. O., & Chenoll, E. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1240267 · Cited by 24
The Role of Gut Microbiota and the Potential Effects of Probiotics in Heart Failure
Petruzziello, C., Saviano, A., Manetti, L. L., Macerola, N., & Ojetti, V. (2024) · Medicina · doi:10.3390/medicina60020271 · Cited by 24
Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients
Lin, Y.-T., Lin, T.-Y., Hung, S.-C., Liu, P.-Y., Wu, P.-H., Chuang, Y.-S., Hung, W.-C., Chiu, Y.-W., Kuo, M.-C., & Wu, C.-Y. (2021) · Microorganisms · doi:10.3390/microorganisms9020286 · Cited by 22
Sun, R., Jin, D., Fei, F., Xu, Z., Cao, B., & Li, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1172963 · Cited by 22
“Among them, the metabolites most closely related to the gut microbiota are tryptophan metabolites, short-chain fatty acids (SCFAs), and bile acids (BAs) (Belizário et al., 2018).”
BackgroundYan, X., He, M., Zheng, J. J., Zhu, T., Zou, Z., Tang, B. H., Yu, Y., & Mai, B. (2020) · Environment International · doi:10.1016/j.envint.2020.106256 · Cited by 22
Moorthy, M., Chong, C. W., Mariño, E., & Palanisamy, U. D. (2022) · Antioxidants · doi:10.3390/antiox11040632 · Cited by 22
Stefano, V. D., Steardo, L., D’Angelo, M., Monaco, F., & Steardo, L. (2025) · Biomedicines · doi:10.3390/biomedicines13061271 · Cited by 21
“Incorporating umPEA into health and wellness programs may serve as a viable approach to promoting immune resilience and fostering healthy aging [41].”
Nabil, Y., Helal, M. M., Qutob, I. A., Dawoud, A. L. A., Allam, S., Haddad, R., Manasrah, G. M., AlEdani, E. M., Sleibi, W., faris, A., et al. (2025) · BMC Neurology · doi:10.1186/s12883-025-04105-8 · Cited by 21
“Dysbiosis refers to an imbalanced microbiome, marked by a deficiency of certain beneficial and harmful bacteria and the metabolites and antigens they generate [3].”
Understanding of E-Learning Programs using WPM MCDM Method
(2022) · REST Journal on Banking Accounting and Business · doi:10.46632/jbab/1/2/3 · Cited by 21
Xie, Y., Tao, S., Pan, B., Yang, W., Shao, W., Fang, X., Han, D., Li, J., Zhang, Y., Chen, R., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131951 · Cited by 21
Jang, H., Joung, H., Chu, J., Cho, M., Kim, Y.-W., Kim, K. H., Shin, C. H., Lee, J., & Ha, J. (2024) · Nutrients · doi:10.3390/nu16244260 · Cited by 21
“Healthy gut microbiota are essential for proper metabolic functions and homeostasis, playing a crucial role in the catabolism and anabolism of energy derived from diet [25,26].”
Xu, Y., Wang, Z., Zhang, S., Xu, J., Pan, Z., Wei, X., Wen, H.-H., Luo, Y.-S., Guo, M.-J., & Zhu, Q. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111473 · Cited by 21
Vaccines, Microbiota and Immunonutrition: Food for Thought
Renzo, L. D., Franza, L., Monsignore, D., Esposito, E., Rio, P., Gasbarrini, A., Gambassi, G., Cianci, R., & LORENZO, A. D. (2022) · Vaccines · doi:10.3390/vaccines10020294 · Cited by 21
“Indeed, this particular microflora is a strong producer of SCFAs, normally inversely correlated with glucose intolerance, central obesity and high blood pressure, the principal hallmarks of metabolic syndrome and T2DM [27].”
BackgroundInfluentialGut Microbiota Host–Gene Interaction
Cuomo, P., Capparelli, R., Alifano, M., Iannelli, A., & Iannelli, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213717 · Cited by 21
Microbiome diversity is a modifiable virulence factor for cryptosporidiosis
Hurle, G. R., Brainard, J. S., & Tyler, K. M. (2023) · Virulence · doi:10.1080/21505594.2023.2273004 · Cited by 20
“Dysbiosis can be defined as a compositional change in gut bacterial communities that results in a temporary lack of diversity, hallmarked by a rise in bacteria which can cause inflammation or bacteria with pathogenic potential [14].”
BackgroundPark, M. A., Park, M., Jang, H., Lee, S. H., Hwang, Y. M., Park, S., Shin, D., & Kim, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299792 · Cited by 21
Passaglia, P., Kanashiro, A., Silva, H. B., Navegantes, L. C. C., Lacchini, R., Cárnio, E. C., & Branco, L. G. S. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.037 · Cited by 20
Dyspepsia and Gut Microbiota in Female Patients with Postcholecystectomy Syndrome
Georgescu, D., Caraba, A., Ionita, I., Lascu, A., Huț, F., Dragan, S., Ancusa, O., Suceava, I., & Lighezan, D. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s342882 · Cited by 20
“It is possible that DB to shift the capacity of the adaptative host response results in a proinflammatory state as a consequence of releasing various interleukins and cytokines.(35,56,57) This study also reports a significant increase of acute phase reactant proteins, such as CRP in patients with PCS, when compared to…”
ResultPolyphenolic Compounds: Orchestrating Intestinal Microbiota Harmony during Aging
Pereira, Q. C., Fortunato, I. M., Oliveira, F. D. S., Alvarez, M. C., dos Santos, T. W., & Ribeiro, M. L. (2024) · Nutrients · doi:10.3390/nu16071066 · Cited by 19
“The resulting perturbations in the intestinal microflora have the potential to precipitate complications and influence the development of various pathological conditions [7,8].”
BackgroundHan, M., Lu, Q., Wang, D., Zhou, K., Jia, C., Teng, L., Hamuti, A., Peng, X., Hu, Y., Li, W., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00950-24 · Cited by 19
“An unhealthy gut microbiota is related to obesity and associated metabolic disorders (18, 19).”
Perspectives in lung microbiome research
Sulaiman, I., Schuster, S., & Segal, L. N. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.06.001 · Cited by 19
“Analysis of the gut microbiome has concentrated on the use of stool samples [2,6-8,10,11], a somewhat easily acquired specimen that is a direct product of transit through the entire gastrointestinal tract.”
BackgroundRen, Y., Tian, Y., Hou, M., Zhao, Y., Li, J., Aftab, U., Rousseau, X., Jiang, R., Kang, X., Tian, Y., et al. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103094 · Cited by 18
“…revealed that the microbial community actively participates in processes such as food digestion, nutrient absorption, production of short-chain fatty acids ( SCFAs ), maintenance of intestinal pH stability, and regulation of the immune system (Beliz (cid:1) ario et al., 2018; de Vos et al., 2022).”
BackgroundLeaky Gut Syndrome: An Interplay Between Nutrients and Dysbiosis
Marcari, A. B., Paiva, A. D., Simon, C. R., & dos Santos, M. E. S. M. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00614-7 · Cited by 18
“The human GM is mainly composed of Firmicutes and Bacteroidetes, the two dominant bacterial phyla, alongside other phyla in smaller proportions [1].”
Ortiz, C., & Martirosyan, D. M. (2024) · Agriculture and Food Bioactive Compounds · doi:10.31989/afbc.v1i12.1525 · Cited by 18
Temperament in Early Childhood Is Associated With Gut Microbiota Composition and Diversity
Ueda, E., Matsunaga, M., Fujihara, H., Kajiwara, T., Takeda, A., Watanabe, S., Hagihara, K., & Myowa, M. (2024) · Developmental Psychobiology · doi:10.1002/dev.22542 · Cited by 18
Lin, Y., Lin, T., Hung, S., Liu, P., Hung, W., Tsai, W., Tsai, Y., Delicano, R. A., Chuang, Y., Wu, P., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030198 · Cited by 17
Gut microbiota and bronchopulmonary dysplasia
Yang, K., He, S., & Dong, W. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25508 · Cited by 17
“It can activate and regulate a range of immune cells such as innate hematolymphoid cells, natural killer cells, and helper lymphocytes.(17) Besides, SCFAs, polysaccharide A, α‐galactosylceramide, and tryptophan metabolites from the gut microbiota activate interleukin‐22, interleukin‐10, interleukin‐21, interleukin‐17,…”
BackgroundThe Importance of the Microbiota in Shaping Women’s Health—The Current State of Knowledge
Krupa-Kotara, K. H., Helisz, P., Gwioździk, W., & Grajek, M. K. (2022) · Applied Microbiology · doi:10.3390/applmicrobiol3010002 · Cited by 17
Underneath the Gut–Brain Axis in IBD—Evidence of the Non-Obvious
Boldyreva, L. V., Evtushenko, A. A., Lvova, M. N., Morozova, K. N., & Владимировна, К. Е. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212125 · Cited by 16
Metagenetic Analysis of the Pregnant Microbiome in Horses
Beckers, K. F., Gomes, V. C. L., Crissman, K. R., Liu, C., Schulz, C. J., Childers, G. W., & Sones, J. L. (2023) · Animals · doi:10.3390/ani13121999 · Cited by 16
Park, J., Choi, T. J., Kang, K. S., & Choi, S.-H. (2021) · Biomolecules · doi:10.3390/biom11020284 · Cited by 16
The complicated relationship between inflammation and metabolic dysfunction
Abtin, S., Ziveh, T., & Rezaee-Tavirani, M. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01729-y · Cited by 16
“On the other hand, various studies indicate that dys - biosis plays a role in the development of a wide range of metabolic disorders, including obesity, type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and cardiovascular disease [ 58 ].”
de Maria, Y. N. L. F., Barbosa, D. A., Menegídio, F. B., Santos, K. B., Humberto, A. C., Alencar, V. C., Silva, J. F. S., de Oliveira, R. C., Júnior, M. L. B., Nunes, L. R., et al. (2021) · Microbiology · doi:10.1099/mic.0.001088 · Cited by 15
The nexus of gut microbiota, diet, and health
Bhattarai, S., & Janaswamy, S. (2022) · Functional Food Science · doi:10.31989/ffs.v2i2.885 · Cited by 16
Interventions for non-alcoholic liver disease: a gut microbial metabolites perspective
Guo, J., Shi, C., Zhang, Q., Deng, W., Zhang, L., Chen, Q., Zhang, D., & Gong, Z. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221138676 · Cited by 16
“TG is degraded in two ways: (1) being transported to peripheral organs in the form of VLDL and (2) producing lipotoxic lipids (diacylglycerols, ceramides, lysophosphatidyl choline species, cholesterol) that induce mitochondrial dysfunction, ER stress, and inflammatory responses, promoting fibrosis to exacerbate NAFLD/…”
BackgroundBhatia, R., Singh, S., Maurya, R., Bhadada, S. K., Bishnoi, M., Chopra, K., Joshi, S. R., & Kondepudi, K. K. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00872-5 · Cited by 14
“LPS binding to the toll-like receptor-4 (TLR-4) activates JNK and nuclear factor-kB (NF-kB) pathways that cause a release of inflammatory mediators such as tumor necrosis factor (TNF-α), interleukin IL-6 and IL-1β and low-grade inflammation (endotoxemia), leading to metabolic complications and other clinical condition…”
BackgroundHan, Y., Li, J., Wang, Y., Zhang, T., Mehmood, T., & Habimana, O. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1595030 · Cited by 14
Mir, P. A., Kumar, N. G., Bhutia, G. T., Chaudhary, P., Kaur, G., & Gupta, S. K. (2026) · GeroScience · doi:10.1007/s11357-025-02062-1 · Cited by 15
Villarreal-Calderón, J. R., Castillo, E. C., Cuellar-Támez, R. X., García-Garza, M. R., Elizondo‐Montemayor, L., & García‐Rivas, G. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01587-4 · Cited by 14
Goudreau, A. D., Everest, C., Nagpal, T. S., Puranda, J. L., Bhattacharjee, J., Vasanthan, T., & Adamo, K. B. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13488 · Cited by 14
Nafady, M. H., Sayed, Z. S., Abdelkawy, D. A., Shebl, M. E., Elsayed, R. A., Ashraf, G. M., Perveen, A., Attia, M. S., & Bahbah, E. I. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220419101205 · Cited by 14
Wu, D., Zhou, H., Hu, Z., Ai, F., Du, W., Yin, Y., & Guo, H. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121651 · Cited by 14
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., Long, C., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04903-7 · Cited by 14
“…intestinal microorganisms not only assist in the digestion and absorption of nutri-ents, but also jointly construct and maintain the intestinal barrier function [14], and play an important role in the regulation of the human immune system to resist the attack of pathogenic bacteria [15, 16].”
BackgroundEwing, L., Skinner, C. M., Pathak, R., Yee, E. U., Krager, K. J., Gurley, P. C., Melnyk, S., Boerma, M., Hauer‐Jensen, M., & Koturbash, I. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.09.042 · Cited by 14
“Some other studies recognize Bacteroides as a pro-inflammatory genus [38].”
BackgroundImmunomodulatory role of Faecalibacterium prausnitzii in obesity and metabolic disorders
Yousefi, B., Mohammadlou, M., Bahar, A., Falalyeyeva, T. M., Kobyliak, N. M., & Eslami, M. (2021) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.21.02759-2 · Cited by 14
Tikunov, A. Y., Shvalov, A. N., Morozov, V. V., Babkin, I. V., Seledtsova, G. V., Voloshina, I. O., Ivanova, I. P., Bardasheva, A. V., Morozova, V. V., Vlassov, V. V., et al. (2022) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj21.100 · Cited by 14
Ru, C., Song, A., Jiang, J., Qiaolongbatu, X., Wu, Z., Qian, F., Shen, S., Zhang, L., Wang, Z., Zhao, W., et al. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.70043 · Cited by 13
“Gut flora dysbiosis is closely associated with the onset of systemic diseases, such as mental disorders and metabolic syndrome, via the microbiome–brain–gut axis [13, 14].”
Miranda, V., Laarej, K., & Cavaliere, C. (2026) · Cells · doi:10.3390/cells15010082 · Cited by 13
“Furthermore, changes in the epithelial microenvironment driven by the microbiota, including shifts in pH and biofilm organisation, impact the accessibility and function of taste receptors [148,149].”
RetractedThe Therapeutic Potential of the Specific Intestinal Microbiome (SIM) Diet on Metabolic Diseases
Chu, N. H. S., Chow, E., & Chan, J. C. N. (2024) · Biology · doi:10.3390/biology13070498 · Cited by 13
“SCFAs also play a crucial role in regulating several leukocyte functions, including the production of pro-inflammatory cytokines such as TNF-α and IL-1 β , anti-inflammatory cytokines, such as IL-10 and TGF β , or glucocorticoids, eicosanoids, and chemokines (e.g., MCP-1 and CINC-2) [27,33].”
BackgroundXenobiotics in Health and Disease: The Two Sides of a Coin: A Clinician’s Perspective
Ramaka, S. (2020) · Open Access Journal of Toxicology · doi:10.19080/oajt.2020.04.5556341 · Cited by 13
Plupjeen, S.-N., Chawjiraphan, W., Charoensiddhi, S., Nitisinprasert, S., & Nakphaichit, M. (2020) · 3 Biotech · doi:10.1007/s13205-020-02282-6 · Cited by 13
Gut Health Optimization in Canines and Felines: Exploring the Role of Probiotics and Nutraceuticals
Atuahene, D., Shaikh, A. M., Balouei, F., & Antwi, A. (2024) · Pets · doi:10.3390/pets1020011 · Cited by 12
Unraveling the gut microbiota-brain axis: Mechanisms, pathophysiology, and therapeutic opportunities
Jiang, C., Nageeb, W. M., Batool, S., Hashish, A., Alkhawagah, S. M., Ibrahim, H. A. A., Zhu, W., Che, C., Li, X., Jin, M., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116224 · Cited by 14
Implications of Gut-Brain axis in the pathogenesis of Psychiatric disorders
Taniguchi, K., Ikeda, Y., Nagase, N., Tsuji, A., Kitagishi, Y., & Matsuda, S. (2021) · AIMS bioengineering · doi:10.3934/bioeng.2021021 · Cited by 12
“In particular, reactive oxygen species (ROS) production has a defense mechanism that could provoke cytotoxicity against several pathogens and decrease the possibility of severe infections [35,36].”
BackgroundGut microbiome and cancer implications: Potential opportunities for fermented foods
Crowder, S. L., Jim, H., Hogue, S., Carson, T. L., & Byrd, D. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188897 · Cited by 12
Ahn, Y., Nam, M. H., & Kim, E. (2020) · Nutrients · doi:10.3390/nu12010205 · Cited by 12
Yozgat, A., Kasapoğlu, B., Can, G., Tanoğlu, A., Sakın, Y. S., Yalçın, K. S., GÜRLER, M., Kaplan, M., Kaban, M. G., KIRSOY, M., et al. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2103-80 · Cited by 12
Gut Microbiome Dysbiosis in Metabolic Syndrome: Current Evidence and Emerging Perspectives
Shehata, F., Dwyer, K. M., McGee, S. L., & Rivera, L. R. (2026) · Nutrients · doi:10.3390/nu18101540 · Cited by 12
“Given the gut microbiota’s central role in maintaining host metabolic homeostasis, dysbiosis induced by dietary, environmental, and lifestyle factors can trigger physiological disturbances that increase susceptibility to MetS [32].”
Human microbiome and cardiovascular diseases
Alam, J., Puppala, V., Uppulapu, S. K., Das, B., & Banerjee, S. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.07.012 · Cited by 11
Belo, T. C. A., Santos, N. C. D. M., Souto, B. S., Rosa, C. P., Santos, A. D. S., Oliveira, K. C., Corsetti, P. P., & de Almeida, L. A. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.105080 · Cited by 12
Tikunov, A. Y., Fedorets, V. A., Shrainer, E., Morozov, V. V., Bystrova, V. I., & Викторовна, Т. Н. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247702 · Cited by 11
Role of curcumin in altering gut microbiota for anti-obesity and anti-hyperlipidemic effects
Feng, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1625098 · Cited by 11
Sfarti, C. V., Ciobica, A. S., Balmuș, I.-M., Ilie, O., Trifan, A. V., Petrea, O. C., Cojocariu, C., Gîrleanu, I., Sîngeap, A.-M., & Stanciu, C. (2020) · Medicina · doi:10.3390/medicina56040196 · Cited by 11
“Subsequently, a series of pro-inflammatory cytokines are activated that further alter protein metabolism [18].”
BackgroundYu, X., Xing, Y., Liu, H., Chang, Y.-M., You, Y., Dou, Y., Liu, B., Wang, Q., Ma, D., Chen, L., et al. (2022) · Nutrients · doi:10.3390/nu14091901 · Cited by 11
“The glyoxylate shunt acts as a microbial survival pathway [35,36] and is essential for the production of bacterial acetate and fatty acid metabolism [37].”
BackgroundDolo, O., Coulibaly, F., Somboro, A. M., Sun, S., Diarra, M., Maïga, A., Boré, S., Fofana, D., Marcelin, A., Diakité, B., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02205-24 · Cited by 10
“functions (2, 3).”
The microbiome is associated with obesity-related metabolome signature in the process of aging
Binyamin, D., Turjeman, S., Asulin, N., Schweitzer, R., & Koren, O. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00811-w · Cited by 10
“These microbially derived metabolites contribute to food digestion, xenobiotic metabolism, and the formation of diverse bioactive molecules 25 .”
Adebiyi, O. E., Adigun, K. O., Adebiyi, A. I., & Odenibi, B. S. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.02.026 · Cited by 10
Fernández‐Serrano, A. B., Moya‐Faz, F. J., Alegría, C. A. G., & Rodríguez, J. C. F. (2022) · Brain and Behavior · doi:10.1002/brb3.2624 · Cited by 10
“Previous studies have shown that it is common in those patients who present body pain and bothersome GI symptoms to be a consequence of a chronic inflammatory state (Belizário et al., 2018).”
BackgroundAli, S. M., Abdel-Gawad, M. M., Azab, M., Hamed, S., Emara, M. M., & Shawky, R. M. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad096 · Cited by 10
Glycerine: an alternative energy source for poultry
GHAYAS, A., Hussain, J., Ahmad, S., Ishaq, H. M., Kamran, Z., Yousaf, M. S., Ahmad, S., Ishaq, W., Munir, S., Ahmed, I., et al. (2023) · World s Poultry Science Journal · doi:10.1080/00439339.2023.2225796 · Cited by 10
“…than 97% (Bartlet and Schneider 2002) and upon absorption in gut, it is altered into glucose by the process of gluconeogenesis (Emmanuel et al. 1983) or directed to oxidation (Rosebrough et al. 1980) for the purpose of energy production via glycolysis and citric acid cycle (Belizário et al. 2018).”
BackgroundHealth Potential of Clery Strawberries: Enzymatic Inhibition and Anti-Candida Activity Evaluation
Cairone, F., Simonetti, G., Орехова, А. В., Casadei, M. A., Zengin, G., & Cesa, S. (2021) · Molecules · doi:10.3390/molecules26061731 · Cited by 10
“It is well known that inflammation is dramatically correlated with cancer and chronic diseases [5] and that gut microbiota-derived products can induce inflammation and contribute to metabolic and degenerative illnesses [6].”
BackgroundHelisz, P., Dziubanek, G., Krupa-Kotara, K. H., Gwioździk, W., Grajek, M. K., & Głogowska‐Ligus, J. (2022) · Nutrients · doi:10.3390/nu14194185 · Cited by 10
“Microorganisms residing in the human large intestine also contribute to nutrient absorption and metabolism, as well as participate in the production of, for example, vitamins B and K [13,14].”
BackgroundDNA Methylation in Adipose Tissue and Metabolic Syndrome
Panchal, S. K., & Brown, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092699 · Cited by 10
“Obesity has been associated with changes in gut microbiota, which is directly impacted by the dietary components [25,26].”
BackgroundEvolving Technologies in Gastrointestinal Microbiome Era and Their Potential Clinical Applications
Ajayi, A., Jolaiya, T. F., & Smith, S. I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082565 · Cited by 10
“The afore mentioned technique offers a natural option to routine medical treatments of chronic ailments by providing direct and effective remedy preventing dysbiosis in the host, thereby improving health conditions [39,40].”
BackgroundPark, Y., Zhang, Q., Fernandes, J. M. O., Wiegertjes, G. F., & Kiron, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.798156 · Cited by 9
Xie, Z., Huang, A., Cai, J., Huang, R. Y., Chen, M., Yu, S., Zhang, F., & Zhu, Z. (2023) · Food Safety and Health · doi:10.1002/fsh3.12025 · Cited by 9
Metagenomics reveals unique gut mycobiome biomarkers in psoriasis
Wang, X., Sun, J., Zhang, X., Chen, W., Cao, J., & Hu, H. (2024) · Skin Research and Technology · doi:10.1111/srt.13822 · Cited by 9
“42,43 Previous studies showed that the proportion of various bacteria with SCFA production capacity, such as Faecalibacterium , Clostridium butyricum , Faecalibacterium prausnitzii , was reduced in the intestines of patients with psoriasis.”
Background
Metadata
- Authors
- Belizário, J. E., Faintuch, J., & Garay-Malpartida, M.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Belizário, José E.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2018-12-09
- Volume
- 2018
- Pages
- 1-12
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC6304917
- OpenAlex
- W2904076340
- Cited by
- 341
- References
- 101
- Citations by year
- 2026: 27 · 2025: 34 · 2024: 55 · 2023: 46 · 2022: 64 · 2021: 47 · 2020: 51 · 2019: 17
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- gut dysbiosis, immunometabolism, macrophage polarization, M1/M2 macrophages, short-chain fatty acids, microbial metabolites, low-grade inflammation, metabolic disorders, obesity, diabetes mellitus, metabolic syndrome, cancer, fecal microbiota transplantation, probiotics, prebiotics, symbiotics, small molecule inhibitors, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Macrophages, Metabolic Diseases, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.